Basilea Says Phase II Derazantinib Data Keep Drug’s Prospects On Track

 
• By Sten Stovall
  
Internal organs
Derazantinib Is In Phase II Testing For Intrahepatic Bile Duct Cancer • Source: Shutterstock

More from Clinical Trials

More from R&D